Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations
Release Date:
In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses therapeutic options for younger, fit patients with AML and no targetable mutations. Topics include:Induction chemotherapy and consolidation therapyUse of gemtuzumab ozogamicinManagement of sinusoidal obstruction syndrome Nursing considerations for younger, fit patients with AMLPresenter:Ashley Leak Bryant, PhD, RN, OCN, FAANAssociate ProfessorSchool of NursingUNC Lineberger Comprehensive Cancer Center University of North Carolina at Chapel HillChapel Hill, North Carolina
Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations